Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government
Argentina has committed to reducing regulatory barriers for Indian pharmaceutical companies, potentially upgrading India's status within its regulatory framework. The move follows bilateral trade discussions aimed at strengthening economic ties in sectors including mining, energy, and digital infrastructure.
Why it matters
Increased pharmaceutical access and cooperation in lithium mining highlight the deepening strategic and economic partnership between India and Latin American nations.
Argentina has committed to reduce barriers to facilitate the entry of the Indian pharmaceutical sector into the South American nation, the Commerce Ministry said on Saturday (August 29, 2026).
This is expected to provide greater opportunities for Indian pharmaceutical companies and contribute to improving access to quality and affordable healthcare in Argentina, it said.
"Argentina has committed to work towards upgrading India from Annex II to Annex I under its pharmaceutical regulatory framework and reducing barriers to entry," it added.
The issue came up for discussions during the visit of Commerce Secretary Rajesh Agarwal to Buenos Aires this week.
He was in the country for the India-Argentina Joint Trade Committee (JTC), which was held on August 24, 2026 at Palacio San Martín, Buenos Aires.
Bilateral trade between India and Argentina crossed USD 6.5 billion in 2025, registering consistent annual growth of over 17%.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in